Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

NCT00412828 is registered in ClinicalTrials.gov with CuraGen Corporation as lead sponsor.

NCT NCT00412828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
Lead sponsor
CuraGen Corporation
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2006
Completion date
May 31, 2011
Enrollment
117 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

unresectable stage iii or stage iv melanoma